Mode
Text Size
Log in / Sign up
N/A Completed N=192 Randomized Double-blind Other

Optimization and Multi-Site Feasibility of Yoga for Chronic Pain in People in YOGAMAT-II - Phase II

Source: ClinicalTrials.gov NCT04641221 ↗
Enrolled (actual)
192
Serious AEs
17.7%
Results posted
Nov 2025
Primary outcomePrimary: Yoga Dosage — 164.5; 99.4; 139.1; 102.2 Total yoga Minutes — p=0.028

Summary

Phase 2 - Multiphase Optimization Strategy (MOST) Optimization Phase: 1. To conduct a factorial experiment that will allow us to evaluate the impact of each of the 4 intervention components on yoga dosage received. We will enroll a total n=192. All participants will receive the core yoga intervention, with random assignment to the four intervention components outlined above. 2. Use results from Phase 2 to choose an efficient combination of intervention components that, together with standard yoga classes, maximizes yoga dosage. 3. Examine mechanisms by which components are hypothesized to work.

Outcome Measures

OutcomeResultp-value
PRIMARY
Yoga Dosage
164.5; 99.4; 139.1; 102.2; 116.6; 154.8 0.028 sig

Eligibility Criteria

Inclusion Criteria

  • Enrolled in MMT or BUP treatment for > 3 months
  • Plan to continue treatment for next 6 months
  • Chronic pain, defined as pain for at least half the days over the previous three months, a mean score of 4 or higher on the Brief Pain Interference Scale (BPI; with reference to chronic pain), and pain severity of 4 or higher on a Visual Analog Scale (0-10) indicating "worst pain in the last week." Pain severity score will also refer to the areas of their body in which they have chronic pain.
  • Aged > 18
  • Proficiency in English sufficient to engage in informed consent in English, understand classes taught in English, and read short sentences
  • Available at least one of the times study classes are offered.

Exclusion Criteria

  • Currently taking yoga classes or practicing yoga at home once per week or more often.
  • Medical conditions that would make participation in yoga unsafe or not possible, including active malignancy treatment, fracture, recent joint surgery, use of assistive ambulatory devices other than a cane. . (In cases where this is unclear, site PI will make final determination based on available evidence.)
  • Severe or progressive neurologic deficits. (In cases where this is unclear, site PI will make final determination based on available evidence.)
  • Other severe disabling chronic medical and/or psychiatric comorbidities deemed by the site PI on a case-by-case basis to prevent safe or adequate participation in the study (e.g., cognitive impairment that prevents a participant from understanding assessments; history of disruptive behavior in medical settings; severe disabling heart failure or lung disease)
  • Surgery requiring overnight hospitalization planned in the next 3 months
  • Pregnancy
  • No access to a reasonably safe, reliable place to engage in personal yoga practice and a private space to participate in online yoga classes
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04641221). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search